Erika Gurzeler
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
VEGF-B is a novel mediator of ER stress which induces cardiac angiogenesis via RGD-binding integrins independent of VEGFR1/NRP activities.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 09, 2024
Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells.
Journal: Frontiers in bioengineering and biotechnology
Published: March 29, 2022
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
Journal: PloS one
Published: June 30, 2021
Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor.
Journal: Biochimica et biophysica acta. General subjects
Published: August 08, 2018
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.
Journal: Diabetes & vascular disease research
Published: March 04, 2018
Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice.
Journal: PloS one
Published: August 03, 2017
Vascular Endothelial Growth Factor-B Induces a Distinct Electrophysiological Phenotype in Mouse Heart.
Journal: Frontiers in physiology
Published: January 20, 2017
High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy.
Journal: Scientific reports
Published: April 30, 2016
Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B167: echocardiography and magnetic resonance imaging study.
Journal: Physiological reports
Published: April 05, 2016
Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.
Journal: Atherosclerosis
Published: February 19, 2015
AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 24, 2012
Last Updated: 09/26/2026